These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 29604900)

  • 1. The Role of Tissue Factor in Cancer-Related Hypercoagulability, Tumor Growth, Angiogenesis and Metastasis and Future Therapeutic Strategies.
    Van Dreden P; Εlalamy Ι; Gerotziafas GT
    Crit Rev Oncog; 2017; 22(3-4):219-248. PubMed ID: 29604900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of flTF and asTF splice variants in various cell strains and tissues.
    Pan L; Yu Y; Yu M; Yao S; Mu Q; Luo G; Xu N
    Mol Med Rep; 2019 Mar; 19(3):2077-2086. PubMed ID: 30664196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between tissue factor and cancer progression: insights from bench and bedside.
    van den Berg YW; Osanto S; Reitsma PH; Versteeg HH
    Blood; 2012 Jan; 119(4):924-32. PubMed ID: 22065595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue Factor: A Conventional or Alternative Target in Cancer Therapy.
    Eisenreich A; Bolbrinker J; Leppert U
    Clin Chem; 2016 Apr; 62(4):563-70. PubMed ID: 26896447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue factor in cancer progression and angiogenesis.
    Ruf W; Yokota N; Schaffner F
    Thromb Res; 2010 Apr; 125 Suppl 2(0 2):S36-8. PubMed ID: 20434002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternatively spliced tissue factor induces angiogenesis through integrin ligation.
    van den Berg YW; van den Hengel LG; Myers HR; Ayachi O; Jordanova E; Ruf W; Spek CA; Reitsma PH; Bogdanov VY; Versteeg HH
    Proc Natl Acad Sci U S A; 2009 Nov; 106(46):19497-502. PubMed ID: 19875693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue factor in cancer and angiogenesis: the molecular link between genetic tumor progression, tumor neovascularization, and cancer coagulopathy.
    Rak J; Milsom C; May L; Klement P; Yu J
    Semin Thromb Hemost; 2006 Feb; 32(1):54-70. PubMed ID: 16479463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue factor isoforms in cancer and coagulation: may the best isoform win.
    Kocatürk B; Versteeg HH
    Thromb Res; 2012 Apr; 129 Suppl 1():S69-75. PubMed ID: 22682138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of tissue factor in cancer.
    Kasthuri RS; Taubman MB; Mackman N
    J Clin Oncol; 2009 Oct; 27(29):4834-8. PubMed ID: 19738116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Splice variants of Tissue Factor and integrin-mediated signaling.
    Srinivasan R; Bogdanov VY
    Thromb Res; 2012 May; 129 Suppl 2():S34-7. PubMed ID: 22425320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue factor and fibrin in tumor angiogenesis.
    Fernandez PM; Patierno SR; Rickles FR
    Semin Thromb Hemost; 2004 Feb; 30(1):31-44. PubMed ID: 15034796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of alternatively spliced tissue factor in pancreatic cancer growth and angiogenesis.
    Signaevsky M; Hobbs J; Doll J; Liu N; Soff GA
    Semin Thromb Hemost; 2008 Mar; 34(2):161-9. PubMed ID: 18645921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternatively spliced tissue factor. A crippled protein in coagulation or a key player in non-haemostatic processes?
    van den Berg YW; Versteeg HH
    Hamostaseologie; 2010 Aug; 30(3):144-9. PubMed ID: 20680231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic determinants of cancer coagulopathy, angiogenesis and disease progression.
    Rak J; Klement P; Yu J
    Vnitr Lek; 2006 Mar; 52 Suppl 1():135-8. PubMed ID: 16637463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interplay between alternatively spliced Tissue Factor and full length Tissue Factor in modulating coagulant activity of endothelial cells.
    Ünlü B; Bogdanov VY; Versteeg HH
    Thromb Res; 2017 Aug; 156():1-7. PubMed ID: 28570958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternatively spliced tissue factor and full-length tissue factor protect cardiomyocytes against TNF-α-induced apoptosis.
    Boltzen U; Eisenreich A; Antoniak S; Weithaeuser A; Fechner H; Poller W; Schultheiss HP; Mackman N; Rauch U
    J Mol Cell Cardiol; 2012 May; 52(5):1056-65. PubMed ID: 22326437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of pro-angiogenic tissue factor expression in hypoxia-induced human lung cancer cells.
    Eisenreich A; Zakrzewicz A; Huber K; Thierbach H; Pepke W; Goldin-Lang P; Schultheiss HP; Pries A; Rauch U
    Oncol Rep; 2013 Jul; 30(1):462-70. PubMed ID: 23604472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation and differential role of the tissue factor isoforms in cardiovascular biology.
    Eisenreich A; Rauch U
    Trends Cardiovasc Med; 2010 Aug; 20(6):199-203. PubMed ID: 22137642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue Factor: Old and New Links with Cancer Biology.
    Versteeg HH
    Semin Thromb Hemost; 2015 Oct; 41(7):747-55. PubMed ID: 26408927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-Specific Silencing of Tissue Factor Suppresses Metastasis and Prevents Cancer-Associated Hypercoagulability.
    Liu S; Zhang Y; Zhao X; Wang J; Di C; Zhao Y; Ji T; Cheng K; Wang Y; Chen L; Qi Y; Li S; Nie G
    Nano Lett; 2019 Jul; 19(7):4721-4730. PubMed ID: 31180684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.